AI assistant
Sending…
Equillium, Inc. — Director's Dealing 2023
Feb 8, 2023
34270_dirs_2023-02-07_576dd374-b2c9-4742-af16-b891c354f7ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Equillium, Inc. (EQ)
CIK: 0001746466
Period of Report: 2022-01-19
Reporting Person: Rothman Joel (Chief Development Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-19 | Employee Stock Option (right to buy) | $3.86 | A | 125000 | Acquired | 2032-01-18 | Common Stock (125000) | Direct |
Footnotes
F1: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
More from Equillium, Inc.
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 25
Annual Report
2026
Mar 25
Major Shareholding Notification
2026
Mar 20
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9